Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa

This study has been completed.
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
AlphaVax, Inc. Identifier:
First received: July 7, 2003
Last updated: June 27, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2005
  Primary Completion Date: July 2005 (Final data collection date for primary outcome measure)
No publications provided by AlphaVax, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):